Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy

1. Squifflet, P.
2. Saad, E.D.
3. Loibl, S.
4. van Mackelenbergh, M.T.
5. Untch, M.
6. Rastogi, P.
7. Gianni, L.
8. Schneeweiss, A.
9. Conte, P.
10. Piccart, M.
11. Bonnefoi, H.
12. Jackisch, C.
13. Nekljudova, V.
14. Tang, G.
15. Valagussa, P.
16. Neate, C.
17. Gelber, R.
18. Poncet, C.
19. Heinzmann, D.
20. Denkert, C.
21. Geyer, C.E.
22. Cortes, J.
23. Guarneri, V.
24. de Azambuja, E.
25. Cameron, D.
26. Ismael, G.
27. Wolmark, N.
28. Cortazar, P.
29. Buyse, M.
30. Show all authors +